Labiana Health (XMAD:LAB) FCF Yield % : 0.00 (As of Jun. 05, 2024)

View and export this data going back to 2022. Start your Free Trial

What is Labiana Health FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Labiana Health's Trailing 12-Month Free Cash Flow is €-0.78 Mil, and Market Cap is €17.04 Mil. Therefore, Labiana Health's FCF Yield % for today is 0.00%.

The historical rank and industry rank for Labiana Health's FCF Yield % or its related term are showing as below:

XMAD:LAB's FCF Yield % is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: -0.19
* Ranked among companies with meaningful FCF Yield % only.

Labiana Health's FCF Margin % for the quarter that ended in Dec. 2022 was 0.00%.

Labiana Health FCF Yield % Historical Data

The historical data trend for Labiana Health's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Labiana Health FCF Yield % Chart

Labiana Health Annual Data

Trend

Dec20

Dec21

Dec22

FCF Yield %

-3.19

Labiana Health Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22
FCF Yield %	-	-	-	-

Competitive Comparison of Labiana Health's FCF Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, Labiana Health's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Labiana Health's FCF Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Labiana Health's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Labiana Health's FCF Yield % falls into.

Labiana Health FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Labiana Health's FCF Yield % for the fiscal year that ended in Dec. 2022 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-0.775	/	24.2634336
	=	-3.19%

Labiana Health's annualized FCF Yield % for the quarter that ended in Dec. 2022 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	0	*	2	/	24.2634336
	=	0.00%

Labiana Health FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Labiana Health FCF Yield % Related Terms

Thank you for viewing the detailed overview of Labiana Health's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Labiana Health (XMAD:LAB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Labiana Health SA (XMAD:LAB) » Definitions » FCF Yield %

Traded in Other Exchanges

N/A

Address

Avenida Europa, 34 1st D, Pozuelo de Alarcon, Madrid, ESP, 28023

Website

https://www.labiana.com

Labiana Health SA is a manufacturer of pharmacological products for veterinary use. The company's activities include GMP manufacturer for EU animal and human health industries, manufacturer specialized in sterile and lyophilized dosage forms, source of development, acquisition, and licensing of molecules such as Fosfomycin Trometamol.